Use of 14-3-3 in the diagnosis of Creutzfeldt-Jakob disease

被引：31

作者：

Green, AJE ^{[1
]}

机构：

[1] Western Gen Hosp, Natl Creutzfeldt Jakob Dis Surveillance Unit, Edinburgh EH4 2XU, Midlothian, Scotland

来源：

BIOCHEMICAL SOCIETY TRANSACTIONS | 2002年 / 30卷

关键词：

cerebrospinal fluid; encephalopathy; prion disease;

D O I：

10.1042/bst0300382

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The transmissible spongiform encephalopathies include human diseases such as Creutzfeldt-Jakob disease (CJD) and kuru as well as animal diseases such as scrapie and bovine spongiform encephalopathy (BSE). The emergence of variant CJD, which is causally related to BSE, has generated much interest in the development of rapid and sensitive diagnostic tests for the pre-mortem diagnosis of CJD. In 1986 two proteins were detected in the cerebrospinal fluid (CSF) of patients with sporadic CJD. These proteins were later demonstrated to be members of the 14-3-3 family, and tests for the detection of CSF 14-3-3 were developed. A number of studies have shown that the detection of CSF 14-3-3 is an accurate test for sporadic CJD, although the results with variant CJD are less promising.

引用

收藏

页码：382 / 386

页数：5

相关论文

共 53 条

[11] Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent [J].

Bruce, ME ;

Will, RG ;

Ironside, JW ;

McConnell, I ;

Drummond, D ;

Suttie, A ;

McCardle, L ;

Chree, A ;

Hope, J ;

Birkett, C ;

Cousens, S ;

Fraser, H ;

Bostock, CJ .

NATURE, 1997, 389 (6650) :498-501

[12]

CHAZOT G, 1996, LANCET, V347, P181

[13] Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD [J].

Collinge, J ;

Sidle, KCL ;

Meads, J ;

Ironside, J ;

Hill, AF .

NATURE, 1996, 383 (6602) :685-690

[14] Creutzfeldt-Jakob disease: diagnostic utility of 14-3-3 protein immunodetection in cerebrospinal fluid [J].

Collins, S ;

Boyd, A ;

Fletcher, A ;

Gonzales, M ;

McLean, CA ;

Byron, K ;

Masters, CL .

JOURNAL OF CLINICAL NEUROSCIENCE, 2000, 7 (03) :203-208

[15] Creutzfeldt-Jakob disease from contaminated growth hormone extracts in France [J].

deVillemeur, TB ;

Deslys, JP ;

Pradel, A ;

Soubrie, C ;

Alperovitch, A ;

Tardieu, M ;

Chaussain, JL ;

Hauw, JJ ;

Dormont, D ;

Ruberg, M ;

Agid, Y .

NEUROLOGY, 1996, 47 (03) :690-695

[16]

DUFFY P, 1974, NEW ENGL J MED, V290, P692

[17] Detection of 14-3-3 protein in the CSF of a patient with Hashimoto's encephalopathy [J].

Echebarría, LEH ;

Saiz, A ;

Graus, F ;

Tejada, J ;

García, JM ;

Clavera, B ;

Fernández, F .

NEUROLOGY, 2000, 54 (07) :1539-1540

[18] 14-3-3 proteins: Structure, function, and regulation [J].

Fu, HA ;

Subramanian, RR ;

Masters, SC .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2000, 40 :617-647

[19] CLINICAL AND PATHOLOGICAL FEATURES AND LABORATORY CONFIRMATION OF CREUTZFELDT-JAKOB DISEASE IN A RECIPIENT OF PITUITARY-DERIVED HUMAN GROWTH-HORMONE [J].

GIBBS, CJ ;

JOY, A ;

HEFFNER, R ;

FRANKO, M ;

MIYAZAKI, M ;

ASHER, DM ;

PARISI, JE ;

BROWN, PW ;

GAJDUSEK, DC .

NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (12) :734-738

[20] Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease [J].

Green, AJE ;

Thompson, EJ ;

Stewart, GE ;

Zeidler, M ;

McKenzie, JM ;

MacLeod, MA ;

Ironside, JW ;

Will, RG ;

Knight, RSG .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2001, 70 (06) :744-748

← 1 2 3 4 5 6 →